Laura Newman
I am a medical journalist and blogger. My stories have appeared in peer-reviewed journals and on the web. In Patient POV, I strive to bring the same rigor to telling stories about patients that I have shown in my previous work, which has featured research scientists and physicians.
Laura can be found on Twitter as @lauranewmanny.
Patient POVI’m on ScienceSeeker
Tag Archives: FDA
Warning Signs No. 2: Metal-on-Metal Hips, Lung Cancer Death Rates, Ecigarette and Food Safety
Tweet It’s a new year and here’s another segment on warning signs. I am glad to see that this month, the hazards of metal-on-metal hips, covered in the first warning signs issue, are being examined. 40% Failure Rate of Johnson … Continue reading
Posted in Lung Cancer, medical devices, safety, smoking, warning signs
Tagged A.S.R. hip, electronic cigarettes, FDA, food safety, Johnson & Johnson, metal-on-metal hips
Leave a comment
Metal-on-Metal Hips: A Tale of Harm, Weak Medical Device-Approval, and Lax Postmarket Scrutiny
Tweet Nearly 1 million metal-on- metal hips have been implanted in patients in the United States, making the US the world’s largest consumer of the implants. According to a BMJ/BBC Newsnight Investigation released today, the “risks associated with these devices … Continue reading
Inattention to Drug Safety in the Elderly
Leaves Generations At Risk
Tweet This post originally appeared in a slightly different form in Scientific American’s guest blog on June 30, 2011. My frail, 92-year-old mother was prescribed 80 mg of the cholesterol-lowering drug, or statin, simvastatin (Zocor) for years, possibly decades. She … Continue reading
Posted in aging, drug safety, falls
Tagged cholesterol, CMS, FDA, HEDIS, pay-for-performance, postmarketing surveillance, simvastatin
2 Comments
Conservative Drug Prescribing:
A Plea for Principles and Action
Tweet Does the concept of “conservative drug prescribing,” where doctors evaluate your medical history, examine you thoroughly, and think of ways to help you, without reaching for the latest new pill, mean much to you? If your experience is anything … Continue reading
Posted in medical education
Tagged conflict of interest, drugs, DTC ads, FDA, FTC, pharmaceutical sponsorship, prescribing, quizzes, teaching
Leave a comment